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Background: The neurohypophyseal hormones oxytocin (OT) and [Arg8]-vasopressin
(AVP) have recently been implicated in cardiac function. This study was designed to
investigate actions of OT and AVP on regulation of the voltage-gated Ca2þ channel in
cardiomyocytes.
Methods and Results: Cultured neonatal rat cardiomyocytes were stimulated with OT or
AVP (108M to 106M) for 24–72 h, followed by real-time PCR and patch clamp studies.
Although OT did not exert any modulatory eﬀect on L-type Ca2þ channel current, as a short-
term eﬀect, stimulation of cardiomyocytes with OT but not AVP decreased the expression of
CaV1.2 mRNA with a reduced L-type Ca
2þ channel current. A transcription factor CREB
mRNA expression was down-regulated by OT treatment, although T-type Ca2þ channels
(CaV3.1, CaV3.2) were unaﬀected by OT or AVP.
Conclusion: OT but not AVP down-regulates L-type Ca2þ channel expression through the
inhibition of CREB transcriptional, suggesting a novel mechanism of OT action in the cardiac
electrophysiology.
(J Arrhythmia 2010; 26: 111–118)
Key words: Neurohypophyseal hormones, Gene transcription, CREB
Introduction
Oxytocin (OT) and [Arg8]-vasopressin (AVP)
are the two major polypeptides secreted by the
neurohypophysis. They are formed in greatest
abundance there, being synthesized mainly in
neurosecretory cells of the paraventricular and
supraoptic nuclei of the hypothalamus and released
via the posterior pituitary on pathophysiological
stimulation.1) Recent studies demonstrate that OT
and AVP are involved in endocrine and neuro-
endocrine regulation of peripheral tissues, includ-
ing the heart,2–4) mainly through receptor-mediated
actions. Interestingly, several studies showed that
OT is synthesized and released from the heart and
vasculature,1,2,5) and that these tissues express an
abundant number of receptors for OT.6,7) Through
the activation of these speciﬁc receptors, OT and
AVP regulate various physiological processes
including hydromineral homeostasis, blood vol-
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ume, blood pressure, and cardiovascular contrac-
tility.8–10)
OT has recently been recognized as a cardiovas-
cular hormone.6,9,11) Oxytocin reportedly reduces
heart rate and force of atrial contractions in isolated
atria from perfused hearts in the absence of a central
control mechanism.9) Although the negative inotrop-
ic and chronotropic eﬀects of OT mediated by
cardiac OT receptors were investigated in several
studies, it is largely unknown whether and how
bradycardiac eﬀects of OT are involved in the
regulation of electrical properties of cardiomyocytes,
including cardiac ion channel expression.
AVP is a peptide hormone that modulates a
number of processes implicated in the pathogenesis
of heart failure.12,13) Clinical studies have shown
that patients with heart failure have chronically
elevated plasma AVP levels, which may contribute
to ﬂuid retention.12,14) Because AVP has adverse
eﬀects on heart failure, AVP activity in the
myocardium and coronary vasculature may be
inﬂuenced by an intrinsic cardiac AVP system.4,14)
In addition to its involvement in the pathogenesis of
heart failure, AVP may play an important role in
the development of cardiac hypertrophy.15) Indeed,
elevated plasma AVP levels have been observed in
experimental animals with left ventricular hyper-
trophy.10) These ﬁndings raise the possibility that
local AVP plays a role in cardiac ion channel
remodeling.
Ca2þ-dependent signaling through L-type and T-
type Ca2þ channels has been implicated in cardiac
hypertrophy.3,16) In addition, voltage-gated L-type
Ca2þ channels play an essential role in the regu-
lation of cardiac contractility by modulating Ca2þ
inﬂux, which is necessary to initiate excitation-
contraction coupling in cardiomyocytes.17) Under
pathological conditions such as congestive heart
failure, Ca2þ channel gene expression and the
number of binding sites for Ca2þ channel ligands
are signiﬁcantly depressed,18) possibly contributing
to abnormalities in contractile performance in the
failing heart. Although regulation of L-type Ca2þ
channel function by subunit phosphorylation is
well-described,19) little is known about the molecu-
lar mechanisms regulating L-type Ca2þ channel
gene expression in cardiomyocytes. Accordingly, we
hypothesized that the cardiovascular eﬀects of OT
and AVP are mediated by alterations in gene
expression for voltage-gated Ca2þ channels. In the
present study, we investigated possible genomic
actions of OT and AVP, focusing on L-type and T-
type Ca2þ channel expression in neonatal cardiac
myocytes.
Methods
Cell culture
Neonatal rat ventricular myocytes were prepared
from 2- to 3-day-old Wistar rats as described
previously.20) The cardiomyocytes were maintained
at 37 C under 5% CO2 in Dulbecco’s modiﬁed
Eagle’s medium (DMEM) supplemented with 10%
fetal bovine serum for 24 h, then the medium was
changed to serum-free condition containing oxytocin
(OT) or [Arg8]-vasopressin (AVP) (108M to
106M) for 24–72 h. The spontaneously beating
myocytes were subjected to electrophysiological
experiments 24–72 h after culture with or without
the hormones.
Chemicals
OT and AVP were purchased from Bachem
(Bachem Peninsula Laboratories, Inc., Switzerland).
All other chemicals were from Wako Pure Chemical
Industries (Osaka, Japan). OT and AVP were
dissolved in 5% acetic acid as stock solutions
(1mM). The ﬁnal concentration of acetic acid in
the cultured medium was 0.01% or less. Prior to
electrophysiological and real-time PCR analyses,
concentration of acetic acid was conﬁrmed not to
signiﬁcantly inﬂuence ICa or Ca
2þ channels mRNA
expression.
Quantitative real-time PCR
Total RNA was extracted from rat neonatal
myocytes using TRIzol (Invitrogen, Carlsbad, CA,
USA) 24 h after the treatment with agents. The
single-stranded cDNA was synthesized from 1 mg
of total RNA using Transcriptor First Strand
cDNA Synthesis Kit (Roche Molecular System Inc,
Alameda, CA, USA). Real-time PCR was performed
on Light Cycler (Roche) using the FastStart DNA
Master SYBR Green I (Roche) as a detection
reagent. The oligonucleotide primers used for
real-time quantitative PCR are listed in Table 1.
Rat glyceraldehydes-3-phosphate dehydrogenase
(GAPDH; GeneBank accession no. M17701) mRNA
was used as an internal control. Data were calculated
by 2CT and presented as fold change of tran-
scripts for Ca2þ channels and transcription factors
genes in myocytes and normalized to GAPDH
(deﬁned as 1.0 fold). The PCR products were size
fractioned by 2% agarose gel electrophoresis.
Electrophysiological measurements
Whole-cell voltage clamp experiments were per-
formed as described previously.20,21) L-type Ca2þ
channel current (ICa.L) was recorded from a holding
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potential (VH) of 40mV or 50mV followed
by various test potentials (VT). ICa.L density was
obtained by normalizing ICa.L to the cell capacitance.
T-type Ca2þ channel current (ICa.T) was recorded by
subtracting the currents obtained by VHP of 50mV
from ones obtained by VHP of 100mV in the same
patch. Activation voltage dependence was obtained
from data, based on the relation IV ¼ Imax
ðV  VrÞðGV=GmaxÞ, where IV and GV are current
and conductance at voltage V; Imax and Gmax are
maximum the current and conductance, and Vr is the
reversal potential. Vr was determined from the
horizontal axis intercept of the ascending limb of
the ICa.L–voltage relation. All experiments were
conducted at 37 C. For measuring ICa.L and ICa.T
the bath solution was composed of Naþ- and Kþ-free
solution containing (mM): TEA-Cl 120, CsCl 6, 4-
AP 5, MgCl2 0.5, DIDS 0.1, HEPES 10, CaCl2 1.8,
and glucose 10 (pH of 7.4 adjusted with TEA-OH).
The pipette solution contained (mM): CsCl 130, Mg-
ATP 2, EGTA 5, and HEPES 10 (pH of 7.2 adjusted
with 1M CsOH).21)
Statistical analysis
Data are expressed as mean SE. Between
groups and among groups comparisons were
conducted with one-way ANOVA followed by
Scheﬀe test. A P value < 0:05 was considered
signiﬁcant.
Results
Long-term effects of AVP and OT on Ca2þ
channel expression
To determine the role of neurohypophyseal hor-
mones in transcriptional regulation of voltage-gated
Ca2þ channels, we quantiﬁed Ca2þ channel isoform
(Cav1.2, Cav1.3, Cav3.1 and Cav3.2) expression in
neonatal rat cardiomyocytes cultured in the presence
of AVP or OT using real-time PCR (Figure 1). No
change in gene expression of Cav1.2, Cav1.3,
Cav3.1, or Cav3.2 was observed when cardiomyo-
cytes were exposed to AVP for 24 h to concentra-
tions of up to 106M. In contrast, as shown in
Figure 1E, treatment of cardiomyocytes with OT
(107M, 106M) resulted in a signiﬁcant decrease
in Cav1.2 mRNA expression. Meanwhile, no
changes in the expression of T-type Ca2þ channel
isoforms (Cav3.1 and Cav3.2) or Cav1.3 L-type Ca
2þ
channel isoform were observed (Figure 1F, G, H). To
determine whether OT-induced changes in Ca2þ
channel genes are dependent on the exposure time,
we assessed these four Ca2þ channel isoforms by
measuring mRNAs at diﬀerent culture durations.
Although OT reduced the expression of Cav1.2
mRNA by 29% when cardiomyocytes were exposed
to OT for 24 h (Figure 2A), no further reduction of
mRNA was observed up to 72 h. In contrast, OT
(107M) did not cause any signiﬁcant changes in
Table 1 Sequence of oligonucleotides used as real-time PCR primers
Target Accession No. Sequence
Cav1.2 NM 012517
F: 50-AGCAACTTCCCTCAGACGTTTG-30
R: 50-GCTTCTCATGGGACGGTGAT-30
Cav1.3 NM 017298
F: 50-CGATGTCCAGTAGGTG-30
R: 50-TGAAGATGTGGTGGTTGA-30
Cav3.1 AF027984
F: 50-TCTCTAGGGCTATAGGCG-30
R: 50-GGAGATTTTGCAGGAGCTAT-30
Cav3.2 AF290213
F: 50-GGCGAAGAAGGCAAAGATGA-30
R: 50-GCGTGACACTGGGCATGTT-30
Csx/Nkx2.5 NM 053651
F: 50-ATCGCGGTGCCGGTGTT-30
R: 50-GCCCGAATTGCCATGTG-30
GATA4 NM 144730 F: 5
0
-GAGGGCGAGCCTGTTT-30
R: 50-GATGGATAGCCTTGTGGG-30
NFATc4 XM 240184 F: 5
0
-CCCTGAGTACAGCAACAAGCG-30
R: 50-AAGGTAGGCGGGCACAAC-30
CREB NM 031017 F: 5
0
-CCACAGATTGCCACATTAGC-30
R: 50-TTGAAAGGATTTCCCTTCGT-30
GAPDH M17701 F: 5
0
-GCCATCAACGACCCCTTCAT-30
R: 50-TTCACACCCATCACAAACAT-30
PCR: polymerase chain reaction
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Cav1.3, Cav3.1, and Cav3.2 mRNA expression for
treatments up to 72 h. Although expression of Cav3.1
mRNA was appreciably increased by OT (107M) at
48 h (p ¼ 0:10) and 72 h (p ¼ 0:19), we did not
further investigate the action of OT on Cav3.1 in the
present study (Figure 2C).
Short- and long-term effects of OT on ICa.L and
ICa.T
We decided to evaluate short- and long-term
eﬀects of OT on Ca2þ channel function, measuring
L-type Ca2þ channel currents (ICa.L) in cardiomyo-
cytes (Figure 3A, B). Amplitudes of ICa.L were not
altered during the short-term treatment of OT
(107M) (Figure 3A), indicating no direct acute
action of OT on ICa.L in cardiomyocytes. The voltage
dependency of ICa.L activation was unaﬀected by OT
as a short-term eﬀect (Figure 3B): half-maximal
voltage (V1=2) and slope factors were 1:5 0:3
mV and 6:7 0:3mV for control, and 0:6
0:4mV and 6:4 0:4mV for OT, respectively.
Similarly, we found that T-type Ca2þ channel
current (ICa.T) was largely unaﬀected by OT
(107M) for 5min: ICa.T at 20mV was 4:9
0:1 pA/pF in control and 5:1 0:1 pA/pF (n ¼ 5)
with OT (107M) (p ¼ 0:33) (data not shown),
indicating no direct acute action of OT on ICa.L and
ICa.T in cardiomyocytes. Thereafter, possible long-
term eﬀects of OT on ICa.L were investigated.
Figure 3C illustrates the long-term eﬀect of OT
(107M, 24–72 h) on cardiomyocytes, demonstrat-
ing a signiﬁcant decrease, 21% at 24 h, in ICa,L.
Longer exposures (48 h, 72 h) of cardiomyocytes to
OT (107M) did not further reduce ICa,L, which is
comparable to the changes in CaV1.2 mRNA
induced by OT at 24–72 h in Figure 3D. These results
verify that the long-term actions of OT selectively
reduce CaV1.2 mRNA expression and ICa.L in
cardiomyocytes.
Long-term effects of OT on transcription factors
Recent studies suggest that the transcription
factors Csx/Nkx2.5, GATA4 and CREB (cyclic
AMP response element binding protein) regulate
transcription of L-type and T-type Ca2þ chan-
nels.20,22) Based on this knowledge, we investigated
whether decreased levels of CaV1.2 mRNA expres-
sion occurs as a result of down-regulation of
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Figure 1 Eﬀects of AVP and OT on mRNA expression for L-type Ca2þ channels (CaV1.2, CaV1.3) and T-type Ca2þchannels
(CaV3.1, CaV3.2) in neonatal cardiomyocytes.
Cardiomyocytes were incubated with AVP (A-D) or OT (E-H) at concentrations of 108 M, 107M or 106M for 24 h. We evaluated
changes in expression of Ca2þ channel isoforms normalized to GAPDH.
Insets, 2% agarose gel electrophoresis showing ampliﬁed fragments. Data are expressed as mean SE (n ¼ 5). p < 0:05, compared with
the vehicle group (0M).
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correlated transcription factors such as Csx/Nkx2.5,
GATA4, NFATc4 and CREB. According to our real-
time PCR study, expression of Csx/Nkx2.5, GATA4
and NFATc4 mRNA was not aﬀected by treatment
of cardiomyocytes with OT (107M) for 24 h
(Figure 4A-C). In contrast, as shown in Figure 4D,
treatment of cardiomyocytes with OT induced a
signiﬁcant (34%) decrease in CREB mRNA. Given
these results, we postulate that OT-dependent tran-
scriptional regulation of CREB plays an important
role in modulating Cav1.2 L-type Ca
2þ channel
expression in cardiomyocytes.
Discussion
The present study reports down-regulation of
CaV1.2 L-type Ca
2þ channels caused by a long-term
action of OT in cardiomyocytes. The key ﬁndings
were: 1) OT at 107M or higher concentration
reduced CaV1.2 expression and ICa,L for 24 h or
longer exposures; 2) OT did not modify expression
of other voltage-gated Ca2þ channel isoforms
(Cav1.3, Cav3.1, Cav3.2); 3) AVP had no eﬀects
on L-type and T-type Ca2þ channel expression; and
4) long-term treatment of cardiomyocytes with OT
reduces expression of the transcription factor CREB.
The novel mechanism of this hormone suggests that
OT not only stimulates myometrial contractility in
late pregnancy or in facilitating milk ejection during
lactation, but also, it regulates cardiac contractility
and chronotropism by modulation of L-type Ca2þ
channel expression.
OT, which is expressed primarily in the hypothal-
amus, is a female reproductive hormone, and its
action in response to changes in pathophysiological
conditions is well established for uterine smooth
muscle and mammary myoepithelial cells as well as
in the central nervous system.23) In isolated smooth
muscle cells from rat myometrium, OT binds to its
receptor which then leads to an increase in intra-
cellular free calcium via the generation of inositol
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Figure 2 Time dependency of the OT eﬀect on mRNA
expression of Ca2þ channel isoforms and on ICa.L.
Cardiomyocytes were incubated with OT at a concentration of
107M for 24–72 h to assess expression of Ca2þ channel isoform
mRNA (A-D). OT eﬀects were evaluated by fractional expression
obtained by channel isoform mRNA in OT-treated cardiomyo-
cytes normalized to those in controls (Con).
Insets, 2% agarose gel electrophoresis showing ampliﬁed frag-
ments. Data are expressed as mean SE (n ¼ 5). p < 0:05,
compared with the vehicle group (Con).
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Figure 3 Shrot- and long-term eﬀects of OT on ICa.L.
(A) Typical example of original ICa.L family traces elicited by step
depolarization from VHP of 40mV, before (Aa) and after (Ab)
application of 107M OT for 5min, together with group data for
ICa.L recorded at a VT of 0mV with or without OT (10
7M) as a
short-term eﬀect (n ¼ 5). (B) Activation voltage dependence of
ICa.L before and after application of OT (10
7 M). (C) Typical
ICa.L traces recorded at a test potential VT of 0mV from a VH of
50mV in cardiomyocytes cultured with vehicle (Con) for 24 h,
107M OT for 24 h, 107M OT for 48 h, and 107M OT for 72 h.
(D) Group data for ICa.L recorded at a VT of 0mV in vehicle-
treated (Con) cells (n ¼ 6), 107M OT for 24 h (n ¼ 6), 107M
OT for 48 h (n ¼ 6), and 107 M OT for 72 h (n ¼ 5).
Data are expressed as mean SE (n ¼ 5, except panel C).
p < 0:05, compared with the vehicle group (Con).
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triphosphate by activation of the Gq/phospholipase
C (PLC) pathway.24) These signals transiently
increase large conductance Ca2þ-activated Kþ
(BKCa) channel-mediated outward currents and
thereby positively inﬂuence myometrial contractili-
ty.25) Apart from its actions on smooth muscle cells,
OT has recently been recognized as a cardiac
hormone that regulates cardiovascular functions.
Gutkowska et al. have demonstrated that OT
perfusion stimulates the release of atrial natriuretic
peptide (ANP) from atrial cardiomyocytes or sinoa-
trial node cells.9) OT-induced ANP release may act
acutely through receptors in cardiomyocytes to
increase cGMP production, resulting in bradycardia
and a reduction in myocardial contraction. Thus,
non-genomic eﬀects of OT on cardiac and vascular
myocytes are presumably mediated by ANP, at least
in part, directly or indirectly through ANP’s potent
diuretic, natriuretic and vasorelaxant actions. Al-
though non-genomic actions of OT on the cardio-
vascular system have recently been recognized,
possible genomic actions of OT in cardiomyocytes
have been largely unknown. In this regard, the
results of our study provide novel insights into the
OT-dependence of the regulation of CaV1.2 L-type
Ca2þ channel expression in cardiomyocytes. We
demonstrate in this study that long-term treatment of
cardiomyocytes with OT results in down-regulation
of the transcription factor CREB, leading to a
reduction in Cav1.2 L-type Ca
2þ channel expression
and, concomitantly, a decrease in ICa,L. Since a
recent study reported that CREB is a dominant
regulator of Cav1.2 transcription in cardiomyo-
cytes,22) it is highly likely that the reduction in
CaV1.2 mRNA by OT (Figure 1, 2) is due to
inhibition of CREB-mediated transcription of the
gene. This mechanism may act as a long-term
antiarrhythmic eﬀect in high OT conditions such as
in pregnancy because several hormones derived from
decidua and amnion are implicated to modulate
cardiac excitability.26)
An obvious question of importance is: How does
OT down-regulate CREB actions? Because the
subcellular mechanism of the OT-induced negative
inotropic eﬀect in the adult heart is involved in
generation of ANP via the activation of oxytocin
receptor-Gq pathways,9) we speculate that OT-
mediated Gq stimulation plays a key role in CREB
down-regulation dependent or independent of ANP’s
actions. It is assumed that Gq-coupled receptors
trigger a cellular Ca2þ loading by means of multiple
Ca2þ entry pathways.27) Although no evidence to
support a physiological association between Gq-
mediated Ca2þ loading and a reduction of CREB
activity is yet documented, intracellular Ca2þ-de-
pendent modiﬁcation of Ca2þ channel expression in
cardiomyocytes is postulated.28) Since transcriptional
down-regulation of the CaV1.2 caused by Ca
2þ-
dependent calcineurin/nuclear factor of activated
T cells (NFAT) pathway has been postulated in
cardiomyocytes,28) our results raise the possibility
that the signaling mechanism related to Gq/PKC
activation may trigger down-regulation of CaV1.2
expression by OT.29) Since we could not determine
the detailed mechanism by which OT suppresses
CREB transcriptional activity, further study is
needed. The other possibility is that OT attenuates
protein kinase A activity by reducing cyclic AMP
production leading to a repression of CREB tran-
scription. This speculation is supported by the fact
that OT receptors are coupled to Gi protein in human
and rat myometrial cells.23,30) Nevertheless the latter
possibility is less likely because acute application of
OT (106M) did not modify ICa.L in cardiomyo-
cytes (Figure 3A,B), which is not consistent with the
assumption that OT decreases cyclic AMP produc-
tion in cardiomyocytes. Inconsistent with our obser-
vation of OT having no short-term eﬀect, L-type
Ca2þ channel current was up-regulated in rat
myometrial cells,31) or down-regulated in smooth
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Figure 4 Quantitative analysis of the eﬀect of OT (107M,
24 h) on mRNA expression for transcription factors.
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muscle cells from pregnant rat uterus by OT.32)
Although the mechanism of L-type Ca2þ channel
modulation by OT is not documented in detail, OT-
receptor dependent signal may relay on the function
and amount of Gi and Gq proteins because OT-
receptors distinctly regulate Gi and Gq depending
upon cell types or hormonal conditions. It is also
proposed that OT may stimulate Ca2þ inﬂux through
a dihydropyridine-insensitive pathway, possibly
through receptor-operated channels. Inﬂux of Ca2þ
by any pathway would increase [Ca2þ]i to activate
phospholipase C to hydrolyze PIP2 to IP3, although
the dominant mechanism of intracellular calcium
release during excitation-contraction coupling does
not depend upon IP3-mediated system in cardiomyo-
cytes. Taken together, the intracellular signaling
mechanisms by which OT down-regulates CaV1.2
L-type Ca2þ channel expression in cardiomyoyctes
are still obscure. Other unidentiﬁed processes may
occur in isolated cardiomyocytes because they have
been removed from the tissue and their autonomic
innervation. Taking into account that maternal
plasma OT concentrations rise sharply—as much
as 10 ng/ml (approximately 108M) during the late
stage of labor in humans33)—it is important to note
that our experiments were carried out at OT levels
that were 1–100 times higher than the maximum
serum OT concentration typically achieved in human
blood. Moreover, because our experiments were
performed in isolated cardiomyocytes from neonatal
rat heart, caution is warranted in generalizing these
data to the human whole heart.
In conclusion, our results have demonstrated that
OT has a novel genomic action on the L-type Ca2þ
channel in cardiomyocytes. We hypothesize that OT
will be shown to play an important physiological
role in control of myocardial contraction, cellular
Ca2þ homeostasis, and Ca2þ overloading-dependent
arrythmogenesis, in addition to its well-described
actions through the production of ANP in the heart.
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